ROIV vs ZTS · rev $8.3M vs P/E 25, rev $2.47B
Roivant Sciences Ltd (ROIV) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
ROIV currently screens at market cap $7.47B. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the ROIV and ZTS stock pages for the full models.
Not investment advice.